Skip to content

ALIVE Israel HealthTech Fund

ALIVE Israel HealthTech Fund is a mid-to-late stage venture capital fund based in Savyon, Israel, focusing on HealthTech investments. It targets startups in Series A and B, aiming to enhance healthcare delivery through scalable technologies.

Founded
2020
Recorded stages
Series A, Series B, Series C, Growth Equity
Recorded regions
Global, North America, Europe, Asia

Online destinations

Find ALIVE Israel HealthTech Fund online

Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.

Official links

Pages the organization runs itself.

Overview

ALIVE Israel HealthTech Fund is a mid-to-late stage investment fund established to optimize value creation across all stages of the investment journey, from clinical trials and FDA approvals to market validation and product adoption. Based in Savyon, Israel, ALIVE supports and accelerates the growth of promising HealthTech technologies through a strategic ecosystem of partners, including leading hospital chains, HMOs, and financial institutions. The fund focuses on innovative platform technologies in sectors such as medical devices, diagnostics, digital health, healthcare IT, and AI/ML, seeking companies with strong management and broad intellectual property protection.

Focus

ALIVE invests in mid-to-late stage companies that are developing innovative platform technologies across various sectors, including medical devices, diagnostics, digital health, healthcare IT, and artificial intelligence. The fund seeks companies with strong management teams, robust intellectual property, and a proven execution track record, positioned to leverage the strategic synergies offered by the ALIVE ecosystem.

Support

ALIVE provides significant value to its portfolio companies through access to a robust clinical network, regulatory expertise, and commercial introductions via partnerships with HMOs and hospitals. The fund's strategic ecosystem enhances the growth potential of its investments, facilitating faster market adoption and scaling.

Questions

What are ALIVE's investment criteria?

ALIVE focuses on mid-to-late stage companies in the HealthTech sector, specifically those developing innovative platform technologies in medical devices, diagnostics, digital health, healthcare IT, and AI. The fund seeks companies with strong management teams, robust intellectual property, and a proven execution track record.

How can I pitch to ALIVE?

Founders can pitch to ALIVE by visiting their website at www.alivevc.com and using the contact email provided. A well-prepared pitch deck should include details about the company's technology, market potential, and team.

What makes ALIVE different from other investors?

ALIVE distinguishes itself through its strategic partnerships with leading hospital chains and HMOs, providing portfolio companies with access to a robust clinical network and regulatory expertise. This enhances the growth potential and market adoption of their investments.

What is the geographic scope of ALIVE's investments?

ALIVE has a global investment focus, with particular interest in the Asian market. The firm aims to support HealthTech companies that are ready to scale and commercialize their solutions internationally.

What is the typical check size for investments?

ALIVE invests in Series A, Series B, Series C, and growth equity stages, with check sizes that align with the needs of mid-to-late stage companies. Specific amounts may vary based on the company's stage and requirements.

What kind of support does ALIVE provide post-investment?

ALIVE offers significant value to its portfolio companies through access to a clinical network, regulatory expertise, and commercial introductions via partnerships with HMOs and hospitals. This support facilitates faster market adoption and scaling of their technologies.

Check your startup’s fit

Check your startup’s fit with ALIVE Israel HealthTech Fund

Similar investors

Organizations that do similar work to ALIVE Israel HealthTech Fund.

All investors
o2h group logoInvestor

Investing in the future of life sciences and technology.

HUMAN CAPITAL logoInvestor

Human Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.

Hamilton Lane logoInvestor

Investing in private markets for over 30 years.

Superscout Pro

Find faster. Show up verified. Keep your deals private.

$99a year, or $12 a month
Get Pro

Is this page right?Reviewed · How the research works

Something's off